Biden administration quietly tells states to prepare to vaccinate children as early as early November
The Biden administration has quietly told states to prepare to vaccinate younger children against COVID-19 next month.
Recently, Pfizer-BioNTech submitted an application the US Food and Drug Administration (FDA) to be the emergency use of Covid . expand vaccine for children between the ages of five and eleven.
An unnamed White House official told… NBC News that the federal government has told state governors it expects approval to come in the coming weeks, as early as early November.
In addition, a Department of Health and Human Services official told the news that the Biden administration has already purchased 65 million pediatric doses of the vaccine from Pfizer.
That’s more than the two doses needed to fully vaccinate the 29 million children in the US who are now eligible.
The White House has reached out to state governors to tell them to prepare to vaccinate children against COVID-19. Pictured: Marisol Gerardo, 9, is held by her mother as she gets a shot in the Pfizer Covid trial at Duke Health in Durham, North Carolina, April 2021
The Biden administration believes an FDA decision on Pfizer-BioNTech’s Covid vaccine in children could come as early as early November. Pictured: Biden speaks after signing three proclamations restoring protection of national monuments, October 2021
According to clinicaltrials.gov, Pfizer’s study worked in younger children the same way it did in older children and adults.
A total of 4,500 younger children aged six months and older were enrolled at nearly 100 clinical trial sites in 26 US states, Finland, Poland and Spain.
Of those children, 2,268 were between the ages of five and eleven.
About half of those in the groups five to 11 received two doses 21 days apart, and the other half received placebo injections.
The team then tested the safety, tolerability and immune response generated by the vaccine by measuring antibody levels in the young subjects.
Pfizer said it had chosen lower doses for COVID-19 vaccine trials in children than those given to teens and adults.
Weekly Covid cases for children reached more than 243,000 in early September, but have since fallen to 148,000 as of last week *above)
Individuals 12 years of age and older will receive two 30 micrograms (μg) doses of the vaccine.
However, children between the ages of five and 11 received doses of 10 g and children aged six months to four years received three g doses.
Unlike the larger adult clinical trial, the pediatric trial did not measure efficacy by comparing the number of COVID-19 cases in the vaccine group with the number in the placebo group.
Instead, scientists looked at levels of neutralizing antibodies in young vaccine recipients and compared the levels to those in adults.
The companies expect data on how well the vaccine works in children between the ages of two and five and between six months and two years by the end of the year.
Recently, the number of pediatric cases has risen from 71,000 per week in early August to more than 243,000 in early September, fueled by the Delta variant.
However, according to the American Academy of Pediatrics, they now appear to be on a downward trend with about 148,000 reported last week.
There have also been 520 pediatric deaths since the start of the pandemic, indicating that children account for less than 0.1 percent of all deaths.
There is currently no evidence that the Delta variant is more dangerous in children than previous virus strains.
Because of this low risk of serious illness, polls have shown that many parents are reluctant to vaccinate their children.
A July 2021 surveyMott Children’s Hospital National Poll on Children’s Health at Michigan Medicine last month found that 39 percent of parents said their children had already received a coronavirus shot.
But 40 percent of parents also said it was ‘unlikely’ that their children would be vaccinated.”
Another opinion poll of Axios/Ipsos in September found that 44 percent of parents of children aged five to 11 said their children were likely to receive a vaccine and 42 percent said their children were unlikely to be vaccinated.